nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadofosveset trisodium—ALB—type 2 diabetes mellitus	0.292	1	CbGaD
Gadofosveset trisodium—ALB—Gliclazide—type 2 diabetes mellitus	0.0977	0.204	CbGbCtD
Gadofosveset trisodium—ALB—Repaglinide—type 2 diabetes mellitus	0.0919	0.192	CbGbCtD
Gadofosveset trisodium—ALB—Rosiglitazone—type 2 diabetes mellitus	0.0767	0.16	CbGbCtD
Gadofosveset trisodium—ALB—Valsartan—type 2 diabetes mellitus	0.0677	0.142	CbGbCtD
Gadofosveset trisodium—ALB—Nateglinide—type 2 diabetes mellitus	0.063	0.132	CbGbCtD
Gadofosveset trisodium—ALB—Glyburide—type 2 diabetes mellitus	0.0425	0.0889	CbGbCtD
Gadofosveset trisodium—ALB—Losartan—type 2 diabetes mellitus	0.0389	0.0813	CbGbCtD
Gadofosveset trisodium—Gadoxetate—ABCC2—type 2 diabetes mellitus	0.00163	1	CrCbGaD
Gadofosveset trisodium—ALB—Selenium Micronutrient Network—CAT—type 2 diabetes mellitus	0.000121	0.00275	CbGpPWpGaD
Gadofosveset trisodium—ALB—Folate Metabolism—CRP—type 2 diabetes mellitus	0.000121	0.00275	CbGpPWpGaD
Gadofosveset trisodium—ALB—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	0.00012	0.0027	CbGpPWpGaD
Gadofosveset trisodium—ALB—SLC-mediated transmembrane transport—SLC5A2—type 2 diabetes mellitus	0.000119	0.00269	CbGpPWpGaD
Gadofosveset trisodium—ALB—Selenium Micronutrient Network—APOB—type 2 diabetes mellitus	0.000118	0.00267	CbGpPWpGaD
Gadofosveset trisodium—ALB—Folate Metabolism—APOA1—type 2 diabetes mellitus	0.000117	0.00266	CbGpPWpGaD
Gadofosveset trisodium—ALB—Platelet degranulation—CD36—type 2 diabetes mellitus	0.000115	0.00261	CbGpPWpGaD
Gadofosveset trisodium—ALB—Selenium Micronutrient Network—SOD2—type 2 diabetes mellitus	0.000115	0.0026	CbGpPWpGaD
Gadofosveset trisodium—ALB—Vitamin B12 Metabolism—SERPINE1—type 2 diabetes mellitus	0.000115	0.00259	CbGpPWpGaD
Gadofosveset trisodium—ALB—Folate Metabolism—ICAM1—type 2 diabetes mellitus	0.000112	0.00252	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—GRB14—type 2 diabetes mellitus	0.00011	0.0025	CbGpPWpGaD
Gadofosveset trisodium—ALB—Response to elevated platelet cytosolic Ca2+—CD36—type 2 diabetes mellitus	0.00011	0.00249	CbGpPWpGaD
Gadofosveset trisodium—ALB—Selenium Micronutrient Network—GPX1—type 2 diabetes mellitus	0.00011	0.00248	CbGpPWpGaD
Gadofosveset trisodium—ALB—Vitamin B12 Metabolism—RELA—type 2 diabetes mellitus	0.000103	0.00233	CbGpPWpGaD
Gadofosveset trisodium—ALB—Platelet degranulation—CALM1—type 2 diabetes mellitus	0.000102	0.00231	CbGpPWpGaD
Gadofosveset trisodium—ALB—Folate Metabolism—INS—type 2 diabetes mellitus	0.000102	0.0023	CbGpPWpGaD
Gadofosveset trisodium—ALB—Selenium Micronutrient Network—MTHFR—type 2 diabetes mellitus	0.000101	0.00229	CbGpPWpGaD
Gadofosveset trisodium—ALB—SLC-mediated transmembrane transport—HK1—type 2 diabetes mellitus	0.000101	0.00229	CbGpPWpGaD
Gadofosveset trisodium—ALB—Platelet degranulation—APOA1—type 2 diabetes mellitus	0.000101	0.00228	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism of lipids and lipoproteins—PTGDS—type 2 diabetes mellitus	0.0001	0.00227	CbGpPWpGaD
Gadofosveset trisodium—ALB—Folate Metabolism—CCL2—type 2 diabetes mellitus	9.99e-05	0.00226	CbGpPWpGaD
Gadofosveset trisodium—ALB—SLC-mediated transmembrane transport—GCKR—type 2 diabetes mellitus	9.77e-05	0.00221	CbGpPWpGaD
Gadofosveset trisodium—ALB—Response to elevated platelet cytosolic Ca2+—CALM1—type 2 diabetes mellitus	9.74e-05	0.0022	CbGpPWpGaD
Gadofosveset trisodium—ALB—Selenium Micronutrient Network—CRP—type 2 diabetes mellitus	9.65e-05	0.00218	CbGpPWpGaD
Gadofosveset trisodium—ALB—Response to elevated platelet cytosolic Ca2+—APOA1—type 2 diabetes mellitus	9.59e-05	0.00217	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism of lipids and lipoproteins—GPD2—type 2 diabetes mellitus	9.52e-05	0.00215	CbGpPWpGaD
Gadofosveset trisodium—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	9.38e-05	0.00051	CcSEcCtD
Gadofosveset trisodium—Fatigue—Gliclazide—type 2 diabetes mellitus	9.36e-05	0.00051	CcSEcCtD
Gadofosveset trisodium—Nausea—Glipizide—type 2 diabetes mellitus	9.34e-05	0.000508	CcSEcCtD
Gadofosveset trisodium—ALB—Selenium Micronutrient Network—APOA1—type 2 diabetes mellitus	9.33e-05	0.00211	CbGpPWpGaD
Gadofosveset trisodium—Vomiting—Glimepiride—type 2 diabetes mellitus	9.33e-05	0.000508	CcSEcCtD
Gadofosveset trisodium—Hypotension—Valsartan—type 2 diabetes mellitus	9.32e-05	0.000508	CcSEcCtD
Gadofosveset trisodium—ALB—Folate Metabolism—SERPINE1—type 2 diabetes mellitus	9.32e-05	0.00211	CbGpPWpGaD
Gadofosveset trisodium—Vision blurred—Losartan—type 2 diabetes mellitus	9.32e-05	0.000507	CcSEcCtD
Gadofosveset trisodium—Vomiting—Sitagliptin—type 2 diabetes mellitus	9.3e-05	0.000506	CcSEcCtD
Gadofosveset trisodium—Pain—Gliclazide—type 2 diabetes mellitus	9.29e-05	0.000506	CcSEcCtD
Gadofosveset trisodium—Constipation—Gliclazide—type 2 diabetes mellitus	9.29e-05	0.000506	CcSEcCtD
Gadofosveset trisodium—Tremor—Losartan—type 2 diabetes mellitus	9.26e-05	0.000504	CcSEcCtD
Gadofosveset trisodium—Rash—Glimepiride—type 2 diabetes mellitus	9.25e-05	0.000503	CcSEcCtD
Gadofosveset trisodium—Dermatitis—Glimepiride—type 2 diabetes mellitus	9.24e-05	0.000503	CcSEcCtD
Gadofosveset trisodium—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	9.24e-05	0.000503	CcSEcCtD
Gadofosveset trisodium—Rash—Sitagliptin—type 2 diabetes mellitus	9.22e-05	0.000502	CcSEcCtD
Gadofosveset trisodium—Dermatitis—Sitagliptin—type 2 diabetes mellitus	9.21e-05	0.000501	CcSEcCtD
Gadofosveset trisodium—Headache—Glimepiride—type 2 diabetes mellitus	9.19e-05	0.0005	CcSEcCtD
Gadofosveset trisodium—Cough—Irbesartan—type 2 diabetes mellitus	9.17e-05	0.000499	CcSEcCtD
Gadofosveset trisodium—Headache—Sitagliptin—type 2 diabetes mellitus	9.16e-05	0.000499	CcSEcCtD
Gadofosveset trisodium—ALB—Response to elevated platelet cytosolic Ca2+—PRKCB—type 2 diabetes mellitus	9.15e-05	0.00207	CbGpPWpGaD
Gadofosveset trisodium—Oedema—Metformin—type 2 diabetes mellitus	9.09e-05	0.000495	CcSEcCtD
Gadofosveset trisodium—Hypertension—Irbesartan—type 2 diabetes mellitus	9.07e-05	0.000494	CcSEcCtD
Gadofosveset trisodium—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	9.05e-05	0.000493	CcSEcCtD
Gadofosveset trisodium—Flushing—Ramipril—type 2 diabetes mellitus	9.04e-05	0.000492	CcSEcCtD
Gadofosveset trisodium—Infection—Metformin—type 2 diabetes mellitus	9.03e-05	0.000491	CcSEcCtD
Gadofosveset trisodium—Paraesthesia—Valsartan—type 2 diabetes mellitus	8.96e-05	0.000488	CcSEcCtD
Gadofosveset trisodium—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	8.95e-05	0.000487	CcSEcCtD
Gadofosveset trisodium—Chest pain—Irbesartan—type 2 diabetes mellitus	8.95e-05	0.000487	CcSEcCtD
Gadofosveset trisodium—Shock—Metformin—type 2 diabetes mellitus	8.94e-05	0.000487	CcSEcCtD
Gadofosveset trisodium—Anxiety—Irbesartan—type 2 diabetes mellitus	8.91e-05	0.000485	CcSEcCtD
Gadofosveset trisodium—Hypersensitivity—Glyburide—type 2 diabetes mellitus	8.91e-05	0.000485	CcSEcCtD
Gadofosveset trisodium—Nervous system disorder—Metformin—type 2 diabetes mellitus	8.91e-05	0.000485	CcSEcCtD
Gadofosveset trisodium—Dyspnoea—Valsartan—type 2 diabetes mellitus	8.9e-05	0.000484	CcSEcCtD
Gadofosveset trisodium—Vertigo—Losartan—type 2 diabetes mellitus	8.88e-05	0.000484	CcSEcCtD
Gadofosveset trisodium—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	8.88e-05	0.000484	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	8.88e-05	0.000483	CcSEcCtD
Gadofosveset trisodium—Syncope—Losartan—type 2 diabetes mellitus	8.87e-05	0.000483	CcSEcCtD
Gadofosveset trisodium—ALB—Selenium Micronutrient Network—ICAM1—type 2 diabetes mellitus	8.87e-05	0.002	CbGpPWpGaD
Gadofosveset trisodium—Paraesthesia—Orlistat—type 2 diabetes mellitus	8.85e-05	0.000482	CcSEcCtD
Gadofosveset trisodium—Skin disorder—Metformin—type 2 diabetes mellitus	8.83e-05	0.00048	CcSEcCtD
Gadofosveset trisodium—Immune system disorder—Ramipril—type 2 diabetes mellitus	8.8e-05	0.000479	CcSEcCtD
Gadofosveset trisodium—Hyperhidrosis—Metformin—type 2 diabetes mellitus	8.79e-05	0.000478	CcSEcCtD
Gadofosveset trisodium—Dyspepsia—Valsartan—type 2 diabetes mellitus	8.78e-05	0.000478	CcSEcCtD
Gadofosveset trisodium—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	8.78e-05	0.000478	CcSEcCtD
Gadofosveset trisodium—Dizziness—Bromocriptine—type 2 diabetes mellitus	8.75e-05	0.000476	CcSEcCtD
Gadofosveset trisodium—Dry mouth—Irbesartan—type 2 diabetes mellitus	8.75e-05	0.000476	CcSEcCtD
Gadofosveset trisodium—Palpitations—Losartan—type 2 diabetes mellitus	8.74e-05	0.000476	CcSEcCtD
Gadofosveset trisodium—Nausea—Glimepiride—type 2 diabetes mellitus	8.71e-05	0.000474	CcSEcCtD
Gadofosveset trisodium—Arrhythmia—Ramipril—type 2 diabetes mellitus	8.7e-05	0.000474	CcSEcCtD
Gadofosveset trisodium—Loss of consciousness—Losartan—type 2 diabetes mellitus	8.69e-05	0.000473	CcSEcCtD
Gadofosveset trisodium—ALB—Vitamin B12 Metabolism—NFKB1—type 2 diabetes mellitus	8.69e-05	0.00196	CbGpPWpGaD
Gadofosveset trisodium—Nausea—Sitagliptin—type 2 diabetes mellitus	8.68e-05	0.000473	CcSEcCtD
Gadofosveset trisodium—Dyspepsia—Orlistat—type 2 diabetes mellitus	8.68e-05	0.000472	CcSEcCtD
Gadofosveset trisodium—Asthenia—Glyburide—type 2 diabetes mellitus	8.68e-05	0.000472	CcSEcCtD
Gadofosveset trisodium—Decreased appetite—Valsartan—type 2 diabetes mellitus	8.67e-05	0.000472	CcSEcCtD
Gadofosveset trisodium—Anorexia—Metformin—type 2 diabetes mellitus	8.66e-05	0.000472	CcSEcCtD
Gadofosveset trisodium—Cough—Losartan—type 2 diabetes mellitus	8.63e-05	0.00047	CcSEcCtD
Gadofosveset trisodium—Urticaria—Gliclazide—type 2 diabetes mellitus	8.63e-05	0.00047	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	8.62e-05	0.000469	CcSEcCtD
Gadofosveset trisodium—Fatigue—Valsartan—type 2 diabetes mellitus	8.6e-05	0.000468	CcSEcCtD
Gadofosveset trisodium—Abdominal pain—Gliclazide—type 2 diabetes mellitus	8.59e-05	0.000467	CcSEcCtD
Gadofosveset trisodium—Body temperature increased—Gliclazide—type 2 diabetes mellitus	8.59e-05	0.000467	CcSEcCtD
Gadofosveset trisodium—Oedema—Irbesartan—type 2 diabetes mellitus	8.58e-05	0.000467	CcSEcCtD
Gadofosveset trisodium—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	8.58e-05	0.000467	CcSEcCtD
Gadofosveset trisodium—ALB—Platelet activation, signaling and aggregation—TRPC6—type 2 diabetes mellitus	8.57e-05	0.00194	CbGpPWpGaD
Gadofosveset trisodium—Decreased appetite—Orlistat—type 2 diabetes mellitus	8.57e-05	0.000467	CcSEcCtD
Gadofosveset trisodium—Pruritus—Glyburide—type 2 diabetes mellitus	8.56e-05	0.000466	CcSEcCtD
Gadofosveset trisodium—Mental disorder—Ramipril—type 2 diabetes mellitus	8.53e-05	0.000465	CcSEcCtD
Gadofosveset trisodium—Constipation—Valsartan—type 2 diabetes mellitus	8.53e-05	0.000465	CcSEcCtD
Gadofosveset trisodium—Infection—Irbesartan—type 2 diabetes mellitus	8.52e-05	0.000464	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	8.51e-05	0.000463	CcSEcCtD
Gadofosveset trisodium—Fatigue—Orlistat—type 2 diabetes mellitus	8.5e-05	0.000463	CcSEcCtD
Gadofosveset trisodium—Hypotension—Metformin—type 2 diabetes mellitus	8.49e-05	0.000462	CcSEcCtD
Gadofosveset trisodium—Malnutrition—Ramipril—type 2 diabetes mellitus	8.48e-05	0.000462	CcSEcCtD
Gadofosveset trisodium—Erythema—Ramipril—type 2 diabetes mellitus	8.48e-05	0.000462	CcSEcCtD
Gadofosveset trisodium—Shock—Irbesartan—type 2 diabetes mellitus	8.44e-05	0.000459	CcSEcCtD
Gadofosveset trisodium—Pain—Orlistat—type 2 diabetes mellitus	8.43e-05	0.000459	CcSEcCtD
Gadofosveset trisodium—Chest pain—Losartan—type 2 diabetes mellitus	8.42e-05	0.000458	CcSEcCtD
Gadofosveset trisodium—ALB—Platelet degranulation—IGF1—type 2 diabetes mellitus	8.42e-05	0.0019	CbGpPWpGaD
Gadofosveset trisodium—Vomiting—Bromocriptine—type 2 diabetes mellitus	8.41e-05	0.000458	CcSEcCtD
Gadofosveset trisodium—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	8.41e-05	0.000458	CcSEcCtD
Gadofosveset trisodium—Anxiety—Losartan—type 2 diabetes mellitus	8.39e-05	0.000457	CcSEcCtD
Gadofosveset trisodium—ALB—Folate Metabolism—RELA—type 2 diabetes mellitus	8.38e-05	0.00189	CbGpPWpGaD
Gadofosveset trisodium—Tachycardia—Irbesartan—type 2 diabetes mellitus	8.37e-05	0.000456	CcSEcCtD
Gadofosveset trisodium—Rash—Bromocriptine—type 2 diabetes mellitus	8.34e-05	0.000454	CcSEcCtD
Gadofosveset trisodium—Dermatitis—Bromocriptine—type 2 diabetes mellitus	8.34e-05	0.000454	CcSEcCtD
Gadofosveset trisodium—Skin disorder—Irbesartan—type 2 diabetes mellitus	8.33e-05	0.000453	CcSEcCtD
Gadofosveset trisodium—Dysgeusia—Ramipril—type 2 diabetes mellitus	8.3e-05	0.000452	CcSEcCtD
Gadofosveset trisodium—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	8.29e-05	0.000451	CcSEcCtD
Gadofosveset trisodium—Headache—Bromocriptine—type 2 diabetes mellitus	8.29e-05	0.000451	CcSEcCtD
Gadofosveset trisodium—Diarrhoea—Glyburide—type 2 diabetes mellitus	8.28e-05	0.00045	CcSEcCtD
Gadofosveset trisodium—Dry mouth—Losartan—type 2 diabetes mellitus	8.23e-05	0.000448	CcSEcCtD
Gadofosveset trisodium—Anorexia—Irbesartan—type 2 diabetes mellitus	8.17e-05	0.000445	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	8.16e-05	0.000444	CcSEcCtD
Gadofosveset trisodium—Paraesthesia—Metformin—type 2 diabetes mellitus	8.16e-05	0.000444	CcSEcCtD
Gadofosveset trisodium—Muscle spasms—Ramipril—type 2 diabetes mellitus	8.15e-05	0.000444	CcSEcCtD
Gadofosveset trisodium—Confusional state—Losartan—type 2 diabetes mellitus	8.14e-05	0.000443	CcSEcCtD
Gadofosveset trisodium—Feeling abnormal—Orlistat—type 2 diabetes mellitus	8.13e-05	0.000442	CcSEcCtD
Gadofosveset trisodium—ALB—SLC-mediated transmembrane transport—SLC2A2—type 2 diabetes mellitus	8.13e-05	0.00184	CbGpPWpGaD
Gadofosveset trisodium—Dyspnoea—Metformin—type 2 diabetes mellitus	8.1e-05	0.000441	CcSEcCtD
Gadofosveset trisodium—Anaphylactic shock—Losartan—type 2 diabetes mellitus	8.07e-05	0.000439	CcSEcCtD
Gadofosveset trisodium—Oedema—Losartan—type 2 diabetes mellitus	8.07e-05	0.000439	CcSEcCtD
Gadofosveset trisodium—ALB—Selenium Micronutrient Network—INS—type 2 diabetes mellitus	8.06e-05	0.00182	CbGpPWpGaD
Gadofosveset trisodium—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	8.06e-05	0.000439	CcSEcCtD
Gadofosveset trisodium—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—type 2 diabetes mellitus	8.02e-05	0.00181	CbGpPWpGaD
Gadofosveset trisodium—Infection—Losartan—type 2 diabetes mellitus	8.02e-05	0.000436	CcSEcCtD
Gadofosveset trisodium—Hypotension—Irbesartan—type 2 diabetes mellitus	8.01e-05	0.000436	CcSEcCtD
Gadofosveset trisodium—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	8e-05	0.000436	CcSEcCtD
Gadofosveset trisodium—Dyspepsia—Metformin—type 2 diabetes mellitus	8e-05	0.000435	CcSEcCtD
Gadofosveset trisodium—ALB—Platelet degranulation—SERPINE1—type 2 diabetes mellitus	7.99e-05	0.00181	CbGpPWpGaD
Gadofosveset trisodium—ALB—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	7.97e-05	0.0018	CbGpPWpGaD
Gadofosveset trisodium—Tremor—Ramipril—type 2 diabetes mellitus	7.94e-05	0.000432	CcSEcCtD
Gadofosveset trisodium—Shock—Losartan—type 2 diabetes mellitus	7.94e-05	0.000432	CcSEcCtD
Gadofosveset trisodium—ALB—Selenium Micronutrient Network—CCL2—type 2 diabetes mellitus	7.93e-05	0.00179	CbGpPWpGaD
Gadofosveset trisodium—Urticaria—Valsartan—type 2 diabetes mellitus	7.93e-05	0.000432	CcSEcCtD
Gadofosveset trisodium—Nervous system disorder—Losartan—type 2 diabetes mellitus	7.91e-05	0.000431	CcSEcCtD
Gadofosveset trisodium—Decreased appetite—Metformin—type 2 diabetes mellitus	7.9e-05	0.00043	CcSEcCtD
Gadofosveset trisodium—Abdominal pain—Valsartan—type 2 diabetes mellitus	7.89e-05	0.000429	CcSEcCtD
Gadofosveset trisodium—Tachycardia—Losartan—type 2 diabetes mellitus	7.88e-05	0.000429	CcSEcCtD
Gadofosveset trisodium—Nausea—Bromocriptine—type 2 diabetes mellitus	7.86e-05	0.000428	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	7.85e-05	0.000427	CcSEcCtD
Gadofosveset trisodium—Fatigue—Metformin—type 2 diabetes mellitus	7.83e-05	0.000426	CcSEcCtD
Gadofosveset trisodium—Urticaria—Orlistat—type 2 diabetes mellitus	7.83e-05	0.000426	CcSEcCtD
Gadofosveset trisodium—Hyperhidrosis—Losartan—type 2 diabetes mellitus	7.8e-05	0.000425	CcSEcCtD
Gadofosveset trisodium—Body temperature increased—Orlistat—type 2 diabetes mellitus	7.79e-05	0.000424	CcSEcCtD
Gadofosveset trisodium—Abdominal pain—Orlistat—type 2 diabetes mellitus	7.79e-05	0.000424	CcSEcCtD
Gadofosveset trisodium—Asthenia—Gliclazide—type 2 diabetes mellitus	7.79e-05	0.000424	CcSEcCtD
Gadofosveset trisodium—Constipation—Metformin—type 2 diabetes mellitus	7.77e-05	0.000423	CcSEcCtD
Gadofosveset trisodium—ALB—SLC-mediated transmembrane transport—GCK—type 2 diabetes mellitus	7.76e-05	0.00175	CbGpPWpGaD
Gadofosveset trisodium—Paraesthesia—Irbesartan—type 2 diabetes mellitus	7.7e-05	0.000419	CcSEcCtD
Gadofosveset trisodium—ALB—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	7.7e-05	0.00174	CbGpPWpGaD
Gadofosveset trisodium—ALB—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	7.7e-05	0.00174	CbGpPWpGaD
Gadofosveset trisodium—Anorexia—Losartan—type 2 diabetes mellitus	7.69e-05	0.000419	CcSEcCtD
Gadofosveset trisodium—Vomiting—Glyburide—type 2 diabetes mellitus	7.69e-05	0.000419	CcSEcCtD
Gadofosveset trisodium—Pruritus—Gliclazide—type 2 diabetes mellitus	7.68e-05	0.000418	CcSEcCtD
Gadofosveset trisodium—Dyspnoea—Irbesartan—type 2 diabetes mellitus	7.65e-05	0.000416	CcSEcCtD
Gadofosveset trisodium—Rash—Glyburide—type 2 diabetes mellitus	7.63e-05	0.000415	CcSEcCtD
Gadofosveset trisodium—Dermatitis—Glyburide—type 2 diabetes mellitus	7.62e-05	0.000415	CcSEcCtD
Gadofosveset trisodium—Vertigo—Ramipril—type 2 diabetes mellitus	7.62e-05	0.000415	CcSEcCtD
Gadofosveset trisodium—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—type 2 diabetes mellitus	7.62e-05	0.00172	CbGpPWpGaD
Gadofosveset trisodium—Syncope—Ramipril—type 2 diabetes mellitus	7.6e-05	0.000414	CcSEcCtD
Gadofosveset trisodium—Headache—Glyburide—type 2 diabetes mellitus	7.58e-05	0.000412	CcSEcCtD
Gadofosveset trisodium—ALB—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	7.57e-05	0.00171	CbGpPWpGaD
Gadofosveset trisodium—Dyspepsia—Irbesartan—type 2 diabetes mellitus	7.55e-05	0.000411	CcSEcCtD
Gadofosveset trisodium—ALB—Platelet activation, signaling and aggregation—ADRA2A—type 2 diabetes mellitus	7.54e-05	0.00171	CbGpPWpGaD
Gadofosveset trisodium—Hypotension—Losartan—type 2 diabetes mellitus	7.54e-05	0.000411	CcSEcCtD
Gadofosveset trisodium—ALB—Platelet activation, signaling and aggregation—TIMP1—type 2 diabetes mellitus	7.51e-05	0.0017	CbGpPWpGaD
Gadofosveset trisodium—Palpitations—Ramipril—type 2 diabetes mellitus	7.49e-05	0.000408	CcSEcCtD
Gadofosveset trisodium—Feeling abnormal—Metformin—type 2 diabetes mellitus	7.49e-05	0.000408	CcSEcCtD
Gadofosveset trisodium—Decreased appetite—Irbesartan—type 2 diabetes mellitus	7.45e-05	0.000406	CcSEcCtD
Gadofosveset trisodium—Loss of consciousness—Ramipril—type 2 diabetes mellitus	7.45e-05	0.000406	CcSEcCtD
Gadofosveset trisodium—Diarrhoea—Gliclazide—type 2 diabetes mellitus	7.43e-05	0.000405	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	7.43e-05	0.000404	CcSEcCtD
Gadofosveset trisodium—ALB—Selenium Micronutrient Network—SERPINE1—type 2 diabetes mellitus	7.41e-05	0.00167	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism of lipids and lipoproteins—OXCT1—type 2 diabetes mellitus	7.41e-05	0.00167	CbGpPWpGaD
Gadofosveset trisodium—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	7.4e-05	0.000403	CcSEcCtD
Gadofosveset trisodium—Cough—Ramipril—type 2 diabetes mellitus	7.4e-05	0.000403	CcSEcCtD
Gadofosveset trisodium—Fatigue—Irbesartan—type 2 diabetes mellitus	7.39e-05	0.000402	CcSEcCtD
Gadofosveset trisodium—Hypersensitivity—Valsartan—type 2 diabetes mellitus	7.35e-05	0.0004	CcSEcCtD
Gadofosveset trisodium—Convulsion—Ramipril—type 2 diabetes mellitus	7.35e-05	0.0004	CcSEcCtD
Gadofosveset trisodium—Pain—Irbesartan—type 2 diabetes mellitus	7.33e-05	0.000399	CcSEcCtD
Gadofosveset trisodium—Constipation—Irbesartan—type 2 diabetes mellitus	7.33e-05	0.000399	CcSEcCtD
Gadofosveset trisodium—Hypersensitivity—Orlistat—type 2 diabetes mellitus	7.26e-05	0.000395	CcSEcCtD
Gadofosveset trisodium—Paraesthesia—Losartan—type 2 diabetes mellitus	7.25e-05	0.000394	CcSEcCtD
Gadofosveset trisodium—Urticaria—Metformin—type 2 diabetes mellitus	7.22e-05	0.000393	CcSEcCtD
Gadofosveset trisodium—Chest pain—Ramipril—type 2 diabetes mellitus	7.22e-05	0.000393	CcSEcCtD
Gadofosveset trisodium—ALB—Metabolism of lipids and lipoproteins—SRD5A1—type 2 diabetes mellitus	7.22e-05	0.00163	CbGpPWpGaD
Gadofosveset trisodium—Dyspnoea—Losartan—type 2 diabetes mellitus	7.2e-05	0.000392	CcSEcCtD
Gadofosveset trisodium—Anxiety—Ramipril—type 2 diabetes mellitus	7.19e-05	0.000392	CcSEcCtD
Gadofosveset trisodium—Nausea—Glyburide—type 2 diabetes mellitus	7.18e-05	0.000391	CcSEcCtD
Gadofosveset trisodium—Abdominal pain—Metformin—type 2 diabetes mellitus	7.18e-05	0.000391	CcSEcCtD
Gadofosveset trisodium—Dizziness—Gliclazide—type 2 diabetes mellitus	7.18e-05	0.000391	CcSEcCtD
Gadofosveset trisodium—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	7.17e-05	0.00039	CcSEcCtD
Gadofosveset trisodium—Asthenia—Valsartan—type 2 diabetes mellitus	7.16e-05	0.00039	CcSEcCtD
Gadofosveset trisodium—Dyspepsia—Losartan—type 2 diabetes mellitus	7.1e-05	0.000387	CcSEcCtD
Gadofosveset trisodium—Asthenia—Orlistat—type 2 diabetes mellitus	7.07e-05	0.000385	CcSEcCtD
Gadofosveset trisodium—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	7.07e-05	0.000385	CcSEcCtD
Gadofosveset trisodium—ALB—Folate Metabolism—NFKB1—type 2 diabetes mellitus	7.07e-05	0.0016	CbGpPWpGaD
Gadofosveset trisodium—Pruritus—Valsartan—type 2 diabetes mellitus	7.06e-05	0.000384	CcSEcCtD
Gadofosveset trisodium—Dry mouth—Ramipril—type 2 diabetes mellitus	7.06e-05	0.000384	CcSEcCtD
Gadofosveset trisodium—ALB—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	7.04e-05	0.00159	CbGpPWpGaD
Gadofosveset trisodium—Decreased appetite—Losartan—type 2 diabetes mellitus	7.02e-05	0.000382	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	7.01e-05	0.000382	CcSEcCtD
Gadofosveset trisodium—Confusional state—Ramipril—type 2 diabetes mellitus	6.98e-05	0.00038	CcSEcCtD
Gadofosveset trisodium—Pruritus—Orlistat—type 2 diabetes mellitus	6.98e-05	0.00038	CcSEcCtD
Gadofosveset trisodium—Fatigue—Losartan—type 2 diabetes mellitus	6.96e-05	0.000379	CcSEcCtD
Gadofosveset trisodium—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	6.92e-05	0.000377	CcSEcCtD
Gadofosveset trisodium—Oedema—Ramipril—type 2 diabetes mellitus	6.92e-05	0.000377	CcSEcCtD
Gadofosveset trisodium—Vomiting—Gliclazide—type 2 diabetes mellitus	6.91e-05	0.000376	CcSEcCtD
Gadofosveset trisodium—Pain—Losartan—type 2 diabetes mellitus	6.9e-05	0.000376	CcSEcCtD
Gadofosveset trisodium—Constipation—Losartan—type 2 diabetes mellitus	6.9e-05	0.000376	CcSEcCtD
Gadofosveset trisodium—ALB—Metabolism of lipids and lipoproteins—HSD17B3—type 2 diabetes mellitus	6.89e-05	0.00156	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism of lipids and lipoproteins—STAR—type 2 diabetes mellitus	6.89e-05	0.00156	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism of lipids and lipoproteins—ACACA—type 2 diabetes mellitus	6.89e-05	0.00156	CbGpPWpGaD
Gadofosveset trisodium—ALB—Platelet activation, signaling and aggregation—PTPN1—type 2 diabetes mellitus	6.87e-05	0.00155	CbGpPWpGaD
Gadofosveset trisodium—Rash—Gliclazide—type 2 diabetes mellitus	6.85e-05	0.000373	CcSEcCtD
Gadofosveset trisodium—Dermatitis—Gliclazide—type 2 diabetes mellitus	6.84e-05	0.000372	CcSEcCtD
Gadofosveset trisodium—Diarrhoea—Valsartan—type 2 diabetes mellitus	6.83e-05	0.000372	CcSEcCtD
Gadofosveset trisodium—Urticaria—Irbesartan—type 2 diabetes mellitus	6.81e-05	0.000371	CcSEcCtD
Gadofosveset trisodium—Shock—Ramipril—type 2 diabetes mellitus	6.81e-05	0.000371	CcSEcCtD
Gadofosveset trisodium—Headache—Gliclazide—type 2 diabetes mellitus	6.8e-05	0.00037	CcSEcCtD
Gadofosveset trisodium—Nervous system disorder—Ramipril—type 2 diabetes mellitus	6.79e-05	0.000369	CcSEcCtD
Gadofosveset trisodium—Abdominal pain—Irbesartan—type 2 diabetes mellitus	6.78e-05	0.000369	CcSEcCtD
Gadofosveset trisodium—Body temperature increased—Irbesartan—type 2 diabetes mellitus	6.78e-05	0.000369	CcSEcCtD
Gadofosveset trisodium—ALB—Platelet activation, signaling and aggregation—RASGRP1—type 2 diabetes mellitus	6.76e-05	0.00153	CbGpPWpGaD
Gadofosveset trisodium—ALB—Vitamin B12 Metabolism—TNF—type 2 diabetes mellitus	6.76e-05	0.00153	CbGpPWpGaD
Gadofosveset trisodium—Tachycardia—Ramipril—type 2 diabetes mellitus	6.75e-05	0.000368	CcSEcCtD
Gadofosveset trisodium—Diarrhoea—Orlistat—type 2 diabetes mellitus	6.75e-05	0.000367	CcSEcCtD
Gadofosveset trisodium—Skin disorder—Ramipril—type 2 diabetes mellitus	6.72e-05	0.000366	CcSEcCtD
Gadofosveset trisodium—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	6.69e-05	0.000364	CcSEcCtD
Gadofosveset trisodium—ALB—Selenium Micronutrient Network—RELA—type 2 diabetes mellitus	6.66e-05	0.00151	CbGpPWpGaD
Gadofosveset trisodium—Feeling abnormal—Losartan—type 2 diabetes mellitus	6.65e-05	0.000362	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	6.6e-05	0.000359	CcSEcCtD
Gadofosveset trisodium—Dizziness—Valsartan—type 2 diabetes mellitus	6.6e-05	0.000359	CcSEcCtD
Gadofosveset trisodium—Anorexia—Ramipril—type 2 diabetes mellitus	6.6e-05	0.000359	CcSEcCtD
Gadofosveset trisodium—Dizziness—Orlistat—type 2 diabetes mellitus	6.52e-05	0.000355	CcSEcCtD
Gadofosveset trisodium—Asthenia—Metformin—type 2 diabetes mellitus	6.52e-05	0.000355	CcSEcCtD
Gadofosveset trisodium—ALB—Selenium Micronutrient Network—PTGS2—type 2 diabetes mellitus	6.47e-05	0.00146	CbGpPWpGaD
Gadofosveset trisodium—Hypotension—Ramipril—type 2 diabetes mellitus	6.47e-05	0.000352	CcSEcCtD
Gadofosveset trisodium—Nausea—Gliclazide—type 2 diabetes mellitus	6.45e-05	0.000351	CcSEcCtD
Gadofosveset trisodium—Pruritus—Metformin—type 2 diabetes mellitus	6.43e-05	0.00035	CcSEcCtD
Gadofosveset trisodium—Urticaria—Losartan—type 2 diabetes mellitus	6.41e-05	0.000349	CcSEcCtD
Gadofosveset trisodium—Body temperature increased—Losartan—type 2 diabetes mellitus	6.38e-05	0.000347	CcSEcCtD
Gadofosveset trisodium—Abdominal pain—Losartan—type 2 diabetes mellitus	6.38e-05	0.000347	CcSEcCtD
Gadofosveset trisodium—Vomiting—Valsartan—type 2 diabetes mellitus	6.34e-05	0.000345	CcSEcCtD
Gadofosveset trisodium—ALB—Hemostasis—ATP2A3—type 2 diabetes mellitus	6.34e-05	0.00143	CbGpPWpGaD
Gadofosveset trisodium—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	6.32e-05	0.000344	CcSEcCtD
Gadofosveset trisodium—ALB—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	6.29e-05	0.00142	CbGpPWpGaD
Gadofosveset trisodium—Rash—Valsartan—type 2 diabetes mellitus	6.29e-05	0.000342	CcSEcCtD
Gadofosveset trisodium—Dermatitis—Valsartan—type 2 diabetes mellitus	6.29e-05	0.000342	CcSEcCtD
Gadofosveset trisodium—ALB—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	6.28e-05	0.00142	CbGpPWpGaD
Gadofosveset trisodium—ALB—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	6.28e-05	0.00142	CbGpPWpGaD
Gadofosveset trisodium—Vomiting—Orlistat—type 2 diabetes mellitus	6.27e-05	0.000341	CcSEcCtD
Gadofosveset trisodium—Headache—Valsartan—type 2 diabetes mellitus	6.25e-05	0.00034	CcSEcCtD
Gadofosveset trisodium—ALB—Metabolism of lipids and lipoproteins—NCOA6—type 2 diabetes mellitus	6.24e-05	0.00141	CbGpPWpGaD
Gadofosveset trisodium—Diarrhoea—Metformin—type 2 diabetes mellitus	6.22e-05	0.000338	CcSEcCtD
Gadofosveset trisodium—Rash—Orlistat—type 2 diabetes mellitus	6.22e-05	0.000338	CcSEcCtD
Gadofosveset trisodium—Paraesthesia—Ramipril—type 2 diabetes mellitus	6.21e-05	0.000338	CcSEcCtD
Gadofosveset trisodium—Dermatitis—Orlistat—type 2 diabetes mellitus	6.21e-05	0.000338	CcSEcCtD
Gadofosveset trisodium—Headache—Orlistat—type 2 diabetes mellitus	6.18e-05	0.000336	CcSEcCtD
Gadofosveset trisodium—Dyspnoea—Ramipril—type 2 diabetes mellitus	6.17e-05	0.000336	CcSEcCtD
Gadofosveset trisodium—Asthenia—Irbesartan—type 2 diabetes mellitus	6.15e-05	0.000335	CcSEcCtD
Gadofosveset trisodium—ALB—Metabolism of lipids and lipoproteins—HSD11B1—type 2 diabetes mellitus	6.14e-05	0.00139	CbGpPWpGaD
Gadofosveset trisodium—ALB—Platelet activation, signaling and aggregation—SOD1—type 2 diabetes mellitus	6.12e-05	0.00138	CbGpPWpGaD
Gadofosveset trisodium—Dyspepsia—Ramipril—type 2 diabetes mellitus	6.09e-05	0.000332	CcSEcCtD
Gadofosveset trisodium—Pruritus—Irbesartan—type 2 diabetes mellitus	6.07e-05	0.00033	CcSEcCtD
Gadofosveset trisodium—ALB—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	6.04e-05	0.00137	CbGpPWpGaD
Gadofosveset trisodium—ALB—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	6.04e-05	0.00137	CbGpPWpGaD
Gadofosveset trisodium—ALB—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	6.03e-05	0.00136	CbGpPWpGaD
Gadofosveset trisodium—Decreased appetite—Ramipril—type 2 diabetes mellitus	6.02e-05	0.000327	CcSEcCtD
Gadofosveset trisodium—Dizziness—Metformin—type 2 diabetes mellitus	6.01e-05	0.000327	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	5.97e-05	0.000325	CcSEcCtD
Gadofosveset trisodium—Fatigue—Ramipril—type 2 diabetes mellitus	5.97e-05	0.000325	CcSEcCtD
Gadofosveset trisodium—Hypersensitivity—Losartan—type 2 diabetes mellitus	5.95e-05	0.000324	CcSEcCtD
Gadofosveset trisodium—ALB—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	5.94e-05	0.00134	CbGpPWpGaD
Gadofosveset trisodium—Nausea—Valsartan—type 2 diabetes mellitus	5.93e-05	0.000323	CcSEcCtD
Gadofosveset trisodium—ALB—Platelet activation, signaling and aggregation—GNB3—type 2 diabetes mellitus	5.92e-05	0.00134	CbGpPWpGaD
Gadofosveset trisodium—Constipation—Ramipril—type 2 diabetes mellitus	5.92e-05	0.000322	CcSEcCtD
Gadofosveset trisodium—Diarrhoea—Irbesartan—type 2 diabetes mellitus	5.87e-05	0.000319	CcSEcCtD
Gadofosveset trisodium—Nausea—Orlistat—type 2 diabetes mellitus	5.86e-05	0.000319	CcSEcCtD
Gadofosveset trisodium—ALB—Platelet activation, signaling and aggregation—IGF2—type 2 diabetes mellitus	5.82e-05	0.00131	CbGpPWpGaD
Gadofosveset trisodium—Asthenia—Losartan—type 2 diabetes mellitus	5.79e-05	0.000315	CcSEcCtD
Gadofosveset trisodium—Vomiting—Metformin—type 2 diabetes mellitus	5.78e-05	0.000315	CcSEcCtD
Gadofosveset trisodium—Rash—Metformin—type 2 diabetes mellitus	5.73e-05	0.000312	CcSEcCtD
Gadofosveset trisodium—Dermatitis—Metformin—type 2 diabetes mellitus	5.72e-05	0.000312	CcSEcCtD
Gadofosveset trisodium—Pruritus—Losartan—type 2 diabetes mellitus	5.71e-05	0.000311	CcSEcCtD
Gadofosveset trisodium—Feeling abnormal—Ramipril—type 2 diabetes mellitus	5.7e-05	0.00031	CcSEcCtD
Gadofosveset trisodium—Headache—Metformin—type 2 diabetes mellitus	5.69e-05	0.00031	CcSEcCtD
Gadofosveset trisodium—Dizziness—Irbesartan—type 2 diabetes mellitus	5.67e-05	0.000309	CcSEcCtD
Gadofosveset trisodium—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—type 2 diabetes mellitus	5.66e-05	0.00128	CbGpPWpGaD
Gadofosveset trisodium—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	5.66e-05	0.000308	CcSEcCtD
Gadofosveset trisodium—ALB—Selenium Micronutrient Network—NFKB1—type 2 diabetes mellitus	5.61e-05	0.00127	CbGpPWpGaD
Gadofosveset trisodium—Diarrhoea—Losartan—type 2 diabetes mellitus	5.52e-05	0.000301	CcSEcCtD
Gadofosveset trisodium—ALB—Platelet degranulation—VEGFA—type 2 diabetes mellitus	5.5e-05	0.00124	CbGpPWpGaD
Gadofosveset trisodium—Urticaria—Ramipril—type 2 diabetes mellitus	5.5e-05	0.000299	CcSEcCtD
Gadofosveset trisodium—ALB—Folate Metabolism—TNF—type 2 diabetes mellitus	5.5e-05	0.00124	CbGpPWpGaD
Gadofosveset trisodium—ALB—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	5.49e-05	0.00124	CbGpPWpGaD
Gadofosveset trisodium—Body temperature increased—Ramipril—type 2 diabetes mellitus	5.47e-05	0.000298	CcSEcCtD
Gadofosveset trisodium—Abdominal pain—Ramipril—type 2 diabetes mellitus	5.47e-05	0.000298	CcSEcCtD
Gadofosveset trisodium—Vomiting—Irbesartan—type 2 diabetes mellitus	5.45e-05	0.000297	CcSEcCtD
Gadofosveset trisodium—ALB—Vitamin B12 Metabolism—IL6—type 2 diabetes mellitus	5.45e-05	0.00123	CbGpPWpGaD
Gadofosveset trisodium—Rash—Irbesartan—type 2 diabetes mellitus	5.41e-05	0.000294	CcSEcCtD
Gadofosveset trisodium—Dermatitis—Irbesartan—type 2 diabetes mellitus	5.4e-05	0.000294	CcSEcCtD
Gadofosveset trisodium—Nausea—Metformin—type 2 diabetes mellitus	5.4e-05	0.000294	CcSEcCtD
Gadofosveset trisodium—ALB—Hemostasis—THBD—type 2 diabetes mellitus	5.39e-05	0.00122	CbGpPWpGaD
Gadofosveset trisodium—Headache—Irbesartan—type 2 diabetes mellitus	5.37e-05	0.000292	CcSEcCtD
Gadofosveset trisodium—Dizziness—Losartan—type 2 diabetes mellitus	5.34e-05	0.000291	CcSEcCtD
Gadofosveset trisodium—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—type 2 diabetes mellitus	5.24e-05	0.00118	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism of lipids and lipoproteins—HSD3B2—type 2 diabetes mellitus	5.22e-05	0.00118	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism of lipids and lipoproteins—LPA—type 2 diabetes mellitus	5.22e-05	0.00118	CbGpPWpGaD
Gadofosveset trisodium—ALB—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	5.14e-05	0.00116	CbGpPWpGaD
Gadofosveset trisodium—Vomiting—Losartan—type 2 diabetes mellitus	5.13e-05	0.000279	CcSEcCtD
Gadofosveset trisodium—ALB—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	5.13e-05	0.00116	CbGpPWpGaD
Gadofosveset trisodium—ALB—Platelet activation, signaling and aggregation—CD36—type 2 diabetes mellitus	5.12e-05	0.00116	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—BHMT—type 2 diabetes mellitus	5.12e-05	0.00116	CbGpPWpGaD
Gadofosveset trisodium—Hypersensitivity—Ramipril—type 2 diabetes mellitus	5.1e-05	0.000278	CcSEcCtD
Gadofosveset trisodium—Nausea—Irbesartan—type 2 diabetes mellitus	5.09e-05	0.000277	CcSEcCtD
Gadofosveset trisodium—Rash—Losartan—type 2 diabetes mellitus	5.09e-05	0.000277	CcSEcCtD
Gadofosveset trisodium—Dermatitis—Losartan—type 2 diabetes mellitus	5.08e-05	0.000277	CcSEcCtD
Gadofosveset trisodium—Headache—Losartan—type 2 diabetes mellitus	5.06e-05	0.000275	CcSEcCtD
Gadofosveset trisodium—ALB—Platelet degranulation—TGFB1—type 2 diabetes mellitus	5.05e-05	0.00114	CbGpPWpGaD
Gadofosveset trisodium—Asthenia—Ramipril—type 2 diabetes mellitus	4.97e-05	0.00027	CcSEcCtD
Gadofosveset trisodium—ALB—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	4.96e-05	0.00112	CbGpPWpGaD
Gadofosveset trisodium—Pruritus—Ramipril—type 2 diabetes mellitus	4.9e-05	0.000267	CcSEcCtD
Gadofosveset trisodium—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—type 2 diabetes mellitus	4.81e-05	0.00109	CbGpPWpGaD
Gadofosveset trisodium—Nausea—Losartan—type 2 diabetes mellitus	4.79e-05	0.000261	CcSEcCtD
Gadofosveset trisodium—ALB—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	4.76e-05	0.00108	CbGpPWpGaD
Gadofosveset trisodium—Diarrhoea—Ramipril—type 2 diabetes mellitus	4.73e-05	0.000258	CcSEcCtD
Gadofosveset trisodium—Dizziness—Ramipril—type 2 diabetes mellitus	4.58e-05	0.000249	CcSEcCtD
Gadofosveset trisodium—ALB—Hemostasis—ATP2A2—type 2 diabetes mellitus	4.55e-05	0.00103	CbGpPWpGaD
Gadofosveset trisodium—ALB—Platelet activation, signaling and aggregation—CALM1—type 2 diabetes mellitus	4.54e-05	0.00103	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—PTGDS—type 2 diabetes mellitus	4.47e-05	0.00101	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—AANAT—type 2 diabetes mellitus	4.47e-05	0.00101	CbGpPWpGaD
Gadofosveset trisodium—ALB—Platelet activation, signaling and aggregation—APOA1—type 2 diabetes mellitus	4.47e-05	0.00101	CbGpPWpGaD
Gadofosveset trisodium—ALB—Folate Metabolism—IL6—type 2 diabetes mellitus	4.44e-05	0.001	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—TRPC6—type 2 diabetes mellitus	4.42e-05	0.000999	CbGpPWpGaD
Gadofosveset trisodium—Vomiting—Ramipril—type 2 diabetes mellitus	4.4e-05	0.00024	CcSEcCtD
Gadofosveset trisodium—ALB—Selenium Micronutrient Network—TNF—type 2 diabetes mellitus	4.37e-05	0.000987	CbGpPWpGaD
Gadofosveset trisodium—Rash—Ramipril—type 2 diabetes mellitus	4.36e-05	0.000238	CcSEcCtD
Gadofosveset trisodium—Dermatitis—Ramipril—type 2 diabetes mellitus	4.36e-05	0.000237	CcSEcCtD
Gadofosveset trisodium—ALB—Hemostasis—F7—type 2 diabetes mellitus	4.34e-05	0.000982	CbGpPWpGaD
Gadofosveset trisodium—Headache—Ramipril—type 2 diabetes mellitus	4.34e-05	0.000236	CcSEcCtD
Gadofosveset trisodium—ALB—Platelet activation, signaling and aggregation—PRKCB—type 2 diabetes mellitus	4.26e-05	0.000964	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism of lipids and lipoproteins—CPT1A—type 2 diabetes mellitus	4.25e-05	0.000962	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—CDO1—type 2 diabetes mellitus	4.24e-05	0.000959	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—GPD2—type 2 diabetes mellitus	4.24e-05	0.000959	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism of lipids and lipoproteins—LIPC—type 2 diabetes mellitus	4.15e-05	0.000937	CbGpPWpGaD
Gadofosveset trisodium—ALB—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	4.13e-05	0.000934	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism of lipids and lipoproteins—CYP11A1—type 2 diabetes mellitus	4.12e-05	0.000932	CbGpPWpGaD
Gadofosveset trisodium—Nausea—Ramipril—type 2 diabetes mellitus	4.11e-05	0.000224	CcSEcCtD
Gadofosveset trisodium—ALB—Metabolism—AK1—type 2 diabetes mellitus	4.05e-05	0.000915	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism of lipids and lipoproteins—CETP—type 2 diabetes mellitus	4e-05	0.000904	CbGpPWpGaD
Gadofosveset trisodium—ALB—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	3.94e-05	0.000891	CbGpPWpGaD
Gadofosveset trisodium—ALB—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	3.94e-05	0.000891	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—ADRA2A—type 2 diabetes mellitus	3.89e-05	0.000879	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—PLAT—type 2 diabetes mellitus	3.87e-05	0.000875	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—TIMP1—type 2 diabetes mellitus	3.87e-05	0.000875	CbGpPWpGaD
Gadofosveset trisodium—ALB—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	3.85e-05	0.00087	CbGpPWpGaD
Gadofosveset trisodium—ALB—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	3.83e-05	0.000865	CbGpPWpGaD
Gadofosveset trisodium—ALB—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	3.8e-05	0.00086	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—MAT1A—type 2 diabetes mellitus	3.73e-05	0.000844	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—SLC5A4—type 2 diabetes mellitus	3.73e-05	0.000844	CbGpPWpGaD
Gadofosveset trisodium—ALB—Platelet activation, signaling and aggregation—IGF1—type 2 diabetes mellitus	3.73e-05	0.000844	CbGpPWpGaD
Gadofosveset trisodium—ALB—Platelet activation, signaling and aggregation—AKT2—type 2 diabetes mellitus	3.73e-05	0.000844	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	3.72e-05	0.000841	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	3.65e-05	0.000825	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—NOS1—type 2 diabetes mellitus	3.64e-05	0.000823	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	3.62e-05	0.000818	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—ENPP1—type 2 diabetes mellitus	3.61e-05	0.000815	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—G6PC—type 2 diabetes mellitus	3.61e-05	0.000815	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—PPP1R3C—type 2 diabetes mellitus	3.61e-05	0.000815	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—HBA2—type 2 diabetes mellitus	3.61e-05	0.000815	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—ND1—type 2 diabetes mellitus	3.61e-05	0.000815	CbGpPWpGaD
Gadofosveset trisodium—ALB—Platelet activation, signaling and aggregation—SERPINE1—type 2 diabetes mellitus	3.55e-05	0.000802	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—PTPN1—type 2 diabetes mellitus	3.54e-05	0.000801	CbGpPWpGaD
Gadofosveset trisodium—ALB—Selenium Micronutrient Network—IL6—type 2 diabetes mellitus	3.52e-05	0.000797	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—GCGR—type 2 diabetes mellitus	3.49e-05	0.00079	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—RASGRP1—type 2 diabetes mellitus	3.48e-05	0.000788	CbGpPWpGaD
Gadofosveset trisodium—ALB—Platelet activation, signaling and aggregation—PIK3R1—type 2 diabetes mellitus	3.39e-05	0.000765	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism of lipids and lipoproteins—CYP1A2—type 2 diabetes mellitus	3.36e-05	0.00076	CbGpPWpGaD
Gadofosveset trisodium—ALB—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	3.35e-05	0.000758	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—CYTB—type 2 diabetes mellitus	3.3e-05	0.000746	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—OXCT1—type 2 diabetes mellitus	3.3e-05	0.000746	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—SRD5A1—type 2 diabetes mellitus	3.21e-05	0.000727	CbGpPWpGaD
Gadofosveset trisodium—ALB—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	3.2e-05	0.000723	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—SOD1—type 2 diabetes mellitus	3.16e-05	0.000714	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—HSD17B3—type 2 diabetes mellitus	3.07e-05	0.000693	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—STAR—type 2 diabetes mellitus	3.07e-05	0.000693	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—ACACA—type 2 diabetes mellitus	3.07e-05	0.000693	CbGpPWpGaD
Gadofosveset trisodium—ALB—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	3.07e-05	0.000693	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—GNB3—type 2 diabetes mellitus	3.05e-05	0.00069	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—IGF2—type 2 diabetes mellitus	3e-05	0.000678	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—ABCC8—type 2 diabetes mellitus	2.94e-05	0.000665	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—CBS—type 2 diabetes mellitus	2.94e-05	0.000665	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—APOB—type 2 diabetes mellitus	2.91e-05	0.000658	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—SLC5A2—type 2 diabetes mellitus	2.83e-05	0.00064	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—COX2—type 2 diabetes mellitus	2.83e-05	0.00064	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—NCOA6—type 2 diabetes mellitus	2.78e-05	0.000629	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	2.78e-05	0.000628	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—HSD11B1—type 2 diabetes mellitus	2.73e-05	0.000618	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—UCP3—type 2 diabetes mellitus	2.73e-05	0.000618	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—UCP2—type 2 diabetes mellitus	2.73e-05	0.000618	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	2.65e-05	0.000599	CbGpPWpGaD
Gadofosveset trisodium—ALB—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	2.64e-05	0.000597	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—CD36—type 2 diabetes mellitus	2.64e-05	0.000597	CbGpPWpGaD
Gadofosveset trisodium—ALB—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	2.63e-05	0.000595	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—PPP2CA—type 2 diabetes mellitus	2.61e-05	0.00059	CbGpPWpGaD
Gadofosveset trisodium—ALB—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	2.61e-05	0.000589	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—PCK1—type 2 diabetes mellitus	2.57e-05	0.000581	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	2.53e-05	0.000572	CbGpPWpGaD
Gadofosveset trisodium—ALB—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	2.52e-05	0.00057	CbGpPWpGaD
Gadofosveset trisodium—ALB—Platelet activation, signaling and aggregation—SRC—type 2 diabetes mellitus	2.5e-05	0.000566	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	2.47e-05	0.000558	CbGpPWpGaD
Gadofosveset trisodium—ALB—Platelet activation, signaling and aggregation—VEGFA—type 2 diabetes mellitus	2.44e-05	0.000551	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—MMP1—type 2 diabetes mellitus	2.41e-05	0.000544	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—HK1—type 2 diabetes mellitus	2.41e-05	0.000544	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	2.4e-05	0.000543	CbGpPWpGaD
Gadofosveset trisodium—ALB—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	2.36e-05	0.000532	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—CALM1—type 2 diabetes mellitus	2.34e-05	0.000529	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—LPA—type 2 diabetes mellitus	2.32e-05	0.000525	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—KCNJ11—type 2 diabetes mellitus	2.32e-05	0.000525	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—HSD3B2—type 2 diabetes mellitus	2.32e-05	0.000525	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—GCKR—type 2 diabetes mellitus	2.32e-05	0.000525	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—APOA1—type 2 diabetes mellitus	2.3e-05	0.000521	CbGpPWpGaD
Gadofosveset trisodium—ALB—Platelet activation, signaling and aggregation—TGFB1—type 2 diabetes mellitus	2.24e-05	0.000506	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	2.23e-05	0.000505	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—ALDOB—type 2 diabetes mellitus	2.23e-05	0.000504	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—PRKCB—type 2 diabetes mellitus	2.2e-05	0.000497	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—NOS2—type 2 diabetes mellitus	2.17e-05	0.000491	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	2.16e-05	0.000489	CbGpPWpGaD
Gadofosveset trisodium—ALB—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	2.12e-05	0.00048	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	2.12e-05	0.000479	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	2.1e-05	0.000474	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—GLP1R—type 2 diabetes mellitus	2.07e-05	0.000468	CbGpPWpGaD
Gadofosveset trisodium—ALB—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	1.99e-05	0.000451	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—SLC2A2—type 2 diabetes mellitus	1.93e-05	0.000437	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—IGF1—type 2 diabetes mellitus	1.92e-05	0.000435	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—AKT2—type 2 diabetes mellitus	1.92e-05	0.000435	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—CPT1A—type 2 diabetes mellitus	1.89e-05	0.000428	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—MTR—type 2 diabetes mellitus	1.89e-05	0.000428	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—NAMPT—type 2 diabetes mellitus	1.86e-05	0.00042	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	1.85e-05	0.000418	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—LIPC—type 2 diabetes mellitus	1.85e-05	0.000417	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—HBA1—type 2 diabetes mellitus	1.85e-05	0.000417	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—GCK—type 2 diabetes mellitus	1.85e-05	0.000417	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—CYP11A1—type 2 diabetes mellitus	1.83e-05	0.000415	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—SERPINE1—type 2 diabetes mellitus	1.83e-05	0.000413	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—SLC9A1—type 2 diabetes mellitus	1.8e-05	0.000407	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—CETP—type 2 diabetes mellitus	1.78e-05	0.000403	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—PIK3R1—type 2 diabetes mellitus	1.75e-05	0.000395	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—NOS3—type 2 diabetes mellitus	1.75e-05	0.000395	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—PSMD6—type 2 diabetes mellitus	1.66e-05	0.000374	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—SNAP25—type 2 diabetes mellitus	1.66e-05	0.000374	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—SREBF1—type 2 diabetes mellitus	1.66e-05	0.000374	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—CTGF—type 2 diabetes mellitus	1.63e-05	0.000368	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—HMGCR—type 2 diabetes mellitus	1.61e-05	0.000364	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.59e-05	0.000359	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—ADRA2A—type 2 diabetes mellitus	1.58e-05	0.000356	CbGpPWpGaD
Gadofosveset trisodium—ALB—Platelet activation, signaling and aggregation—AKT1—type 2 diabetes mellitus	1.56e-05	0.000352	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—CYP2E1—type 2 diabetes mellitus	1.51e-05	0.000342	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—SLC2A1—type 2 diabetes mellitus	1.5e-05	0.000339	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—CYP1A2—type 2 diabetes mellitus	1.5e-05	0.000339	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—CYP3A4—type 2 diabetes mellitus	1.46e-05	0.00033	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.45e-05	0.000329	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—SLC2A4—type 2 diabetes mellitus	1.44e-05	0.000325	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—GCG—type 2 diabetes mellitus	1.44e-05	0.000325	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—SRC—type 2 diabetes mellitus	1.29e-05	0.000292	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—VEGFA—type 2 diabetes mellitus	1.26e-05	0.000284	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—GNB3—type 2 diabetes mellitus	1.24e-05	0.00028	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.24e-05	0.00028	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—HMOX1—type 2 diabetes mellitus	1.23e-05	0.000279	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—CAT—type 2 diabetes mellitus	1.22e-05	0.000275	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—APOB—type 2 diabetes mellitus	1.18e-05	0.000267	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—TGFB1—type 2 diabetes mellitus	1.15e-05	0.000261	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—GSTM1—type 2 diabetes mellitus	1.15e-05	0.00026	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—LPL—type 2 diabetes mellitus	1.13e-05	0.000255	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—ADCY5—type 2 diabetes mellitus	1.1e-05	0.000249	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—GPX1—type 2 diabetes mellitus	1.1e-05	0.000249	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—CD36—type 2 diabetes mellitus	1.07e-05	0.000242	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—PPP2CA—type 2 diabetes mellitus	1.06e-05	0.000239	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—MTHFR—type 2 diabetes mellitus	1.01e-05	0.000229	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—PPARA—type 2 diabetes mellitus	9.95e-06	0.000225	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—AGT—type 2 diabetes mellitus	9.64e-06	0.000218	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—CALM1—type 2 diabetes mellitus	9.48e-06	0.000214	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—APOE—type 2 diabetes mellitus	9.44e-06	0.000214	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—APOA1—type 2 diabetes mellitus	9.34e-06	0.000211	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—PPARG—type 2 diabetes mellitus	8.23e-06	0.000186	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—INS—type 2 diabetes mellitus	8.07e-06	0.000182	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—AKT1—type 2 diabetes mellitus	8.02e-06	0.000181	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—PIK3R1—type 2 diabetes mellitus	7.08e-06	0.00016	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—NOS3—type 2 diabetes mellitus	7.08e-06	0.00016	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—PTGS2—type 2 diabetes mellitus	6.47e-06	0.000146	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—AKT1—type 2 diabetes mellitus	3.25e-06	7.35e-05	CbGpPWpGaD
